## MOA
- 抑制蛋白質合成
	- 50S ribosomal subunit
	- 抑制 ribosomal peptidyl transferase
- 對 P-site of the ribosome 具活性
## SAR
- C14 substituent
	- 對結合 peptidyl transferase center (PTC) 重要
## 特色
- 第四個 pleuromutilin class
	- 第一個被系統性使用
- 口服和IV
- 不容易產生抗藥性
- bacteriostatic
- broad spectrum
	- aerobic gram-positive pathogens
	- fastidious gram-negative organisms (e.g., Haemophilus influenzae and Moraxella catarrhalis)
	-  atypical bacteria (e.g., Mycoplasma pneumoniae and Chlamydophila pneumoniae)
- CYP3A4 代謝
- 副作用
	- 口服
		- diarrhea, nausea, vomiting, and hepatic    enzyme elevation
	- injection
		- hypokalemia, insomnia headache, nausea, and hepatic enzyme elevation
## 用途
- 核准用於治療
	- community-acquired bacterial pneumonia (CABP)

![[Pasted image 20230504230317.png]]